Literature DB >> 33475414

Decreasing vaccine hesitancy with extended health knowledge: Evidence from a longitudinal randomized controlled trial.

Sarah Eitze1, Dorothee Heinemeier1, Nora Katharina Schmid-Küpke2, Cornelia Betsch1.   

Abstract

This study assesses whether combining information about diseases and sequelae supports learning about disease risks and influences related health behavior (vaccination).
OBJECTIVE: To test whether extending knowledge about the risks of primary diseases (e.g., influenza) with causally linked secondary diseases (sequelae such as sepsis) can decrease vaccine hesitancy in older adults, who are especially vulnerable to primary and secondary diseases.
METHOD: In a preregistered longitudinal online experiment, 585 German participants > 60 years of age were randomly assigned to a 3 (time: before and after leaflet presentation, 3-month follow-up; within) × 3 (educational leaflet type: sepsis leaflet, traditional vaccination leaflet, and control leaflet; between) mixed-measurements design. The assessed outcomes were knowledge about influenza, pneumococci, and sepsis; risk perceptions; and immediate and long-term vaccination intention and behavior for pneumococcal and influenza vaccinations.
RESULTS: The sepsis leaflet immediately increased the knowledge about influenza (effect size, η² = .080), pneumococci (η² = .071) and sepsis (η² = .113), risk perceptions (η² = .007), and intentions for both vaccinations (both η² = .015). Behavior during the follow-up did not differ between the conditions. Additional mediation analysis showed that increased knowledge immediately after the experiment predicted increased risk perceptions and intentions 3 months later (binfluenza = .060; bpneumococci = .055).
CONCLUSION: Because immediate increases in knowledge and risk perceptions did not change behavior in the long term, extended knowledge interventions might be more effective in locations where positive intention can directly turn into action, such as doctors' clinics. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Entities:  

Year:  2021        PMID: 33475414     DOI: 10.1037/hea0001045

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  6 in total

1.  Using the integrative model of behavioural prediction to understand COVID-19 vaccine hesitancy behaviour.

Authors:  John Romate; Eslavath Rajkumar; Rajgopal Greeshma
Journal:  Sci Rep       Date:  2022-06-04       Impact factor: 4.996

2.  Determining the Cutoff Points of the 5C Scale for Assessment of COVID-19 Vaccines Psychological Antecedents among the Arab Population: A Multinational Study.

Authors:  Ramy Mohamed Ghazy; Samar Abd ElHafeez; Ramy Shaaban; Iffat Elbarazi; Marwa Shawky Abdou; Ahmed Ramadan; Khalid A Kheirallah
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

3.  Hesitancy in COVID-19 vaccine uptake and its associated factors among the general adult population: a cross-sectional study in six Southeast Asian countries.

Authors:  Roy Rillera Marzo; Waqas Sami; Md Zakiul Alam; Swosti Acharya; Kittisak Jermsittiparsert; Karnjana Songwathana; Nhat Tan Pham; Titik Respati; Erwin Martinez Faller; Aries Moralidad Baldonado; Yadanar Aung; Sharmila Mukund Borkar; Mohammad Yasir Essar; Sunil Shrestha; Siyan Yi
Journal:  Trop Med Health       Date:  2022-01-05

4.  COVID-19 vaccine hesitancy among the adult population in Bangladesh: A nationwide cross-sectional survey.

Authors:  Mohammad Bellal Hossain; Md Zakiul Alam; Md Syful Islam; Shafayat Sultan; Md Mahir Faysal; Sharmin Rima; Md Anwer Hossain; Abdullah Al Mamun
Journal:  PLoS One       Date:  2021-12-09       Impact factor: 3.240

Review 5.  Determinants for COVID-19 vaccine hesitancy in the general population: a systematic review of reviews.

Authors:  Aysegul Humeyra Kafadar; Gamze Gizem Tekeli; Katy A Jones; Blossom Stephan; Tom Dening
Journal:  Z Gesundh Wiss       Date:  2022-09-19

Review 6.  Determinants of influenza vaccine hesitancy among pregnant women in Europe: a systematic review.

Authors:  Gbadebo Collins Adeyanju; Elena Engel; Laura Koch; Tabea Ranzinger; Imtiaz Bin Mohammed Shahid; Micheal G Head; Sarah Eitze; Cornelia Betsch
Journal:  Eur J Med Res       Date:  2021-09-28       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.